Literature DB >> 2385126

Lymph node metastasis in resectable esophageal cancer.

S Abe1, M Tachibana, M Shiraishi, T Nakamura.   

Abstract

The prognostic significance of lymph node metastasis was analyzed in 41 patients with locally resectable epidermoid carcinoma of the esophagus. The 5-year survival rate was 50.9% if no metastases or only single node metastasis was present and 29.8% when the lymph node metastasis was confined to one anatomic compartment. All patients with metastasis to two nodes died within 4 years of operation, and all with involvement of three nodes or more died within 3 years. Even with no metastases or single node metastasis, three of 22 patients (13.6%) died of recurrence or metastasis or a combination of the two. Although nodal dissection may be beneficial for selected patients, our results indicate that the survival period is short in the presence of a small number of lymph node metastases, even if the local disease is resectable and despite nodal dissection. Cure is unlikely when cervical or abdominal nodes are involved, and a conservative approach may be indicated for such patients.

Entities:  

Mesh:

Year:  1990        PMID: 2385126

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

Review 1.  Lymph node dissection.

Authors:  T P Hennessy
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

2.  Impact of lymph node metastasis on survival with early gastric cancer.

Authors:  Y Seto; H Nagawa; T Muto
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

3.  Role of endoscopic ultrasound in the preoperative assessment of patients with oesophageal cancer.

Authors:  J Vickers
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

4.  Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA.

Authors:  M Kano; Y Shimada; J Kaganoi; T Sakurai; Z Li; F Sato; G Watanabe; M Imamura
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.